These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 16671331
1. Selective angiotensin receptor antagonism with valsartan decreases arterial stiffness independently of blood pressure lowering in hypertensive patients. Nakamura T, Fujii S, Hoshino J, Saito Y, Mizuno H, Saito Y, Kurabayashi M. Hypertens Res; 2005 Dec; 28(12):937-43. PubMed ID: 16671331 [Abstract] [Full Text] [Related]
3. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors. Rehman A, Rahman AR, Rasool AH. J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720 [Abstract] [Full Text] [Related]
4. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension. Miyajima K, Minatoguchi S, Ito Y, Hukunishi M, Matsuno Y, Kakami M, Kawasaki M, Nishigaki K, Takemura G, Fujiwara H. Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209 [Abstract] [Full Text] [Related]
5. Effect of baseline and changes in systolic blood pressure over time on the effectiveness of valsartan in the Valsartan Heart Failure Trial. Anand IS, Rector TS, Kuskowski M, Thomas S, Holwerda NJ, Cohn JN. Circ Heart Fail; 2008 May; 1(1):34-42. PubMed ID: 19808268 [Abstract] [Full Text] [Related]
7. [Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives]. Weisser B, Vetter H, Mengden T. Dtsch Med Wochenschr; 2003 Mar 14; 128(11):541-4. PubMed ID: 12635025 [Abstract] [Full Text] [Related]
9. Is renoprotection by angiotensin receptor blocker dependent on blood pressure?: the Saitama Medical School, Albuminuria Reduction in Diabetics with Valsartan (STAR) study. Katayama S, Yagi S, Yamamoto H, Yamaguchi M, Izumida T, Noguchi Y, Inaba M, Inukai K. Hypertens Res; 2007 Jun 14; 30(6):529-33. PubMed ID: 17664856 [Abstract] [Full Text] [Related]
10. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial. Hermida RC, Ayala DE, Khder Y, Calvo C. Clin Ther; 2008 Jan 14; 30(1):108-20. PubMed ID: 18343247 [Abstract] [Full Text] [Related]
11. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I. Clin Ther; 2007 Feb 14; 29(2):279-89. PubMed ID: 17472820 [Abstract] [Full Text] [Related]
12. Effects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodeling in hypertensive patients on chronic peritoneal dialysis. Shigenaga A, Tamura K, Dejima T, Ozawa M, Wakui H, Masuda S, Azuma K, Tsurumi-Ikeya Y, Mitsuhashi H, Okano Y, Kokuho T, Sugano T, Ishigami T, Toya Y, Uchino K, Tokita Y, Umemura S. Nephron Clin Pract; 2009 Feb 14; 112(1):c31-40. PubMed ID: 19342867 [Abstract] [Full Text] [Related]
13. Smoking and antihypertensive medication: interaction between blood pressure reduction and arterial stiffness. Matsui Y, Kario K, Ishikawa J, Hoshide S, Eguchi K, Shimada K. Hypertens Res; 2005 Aug 14; 28(8):631-8. PubMed ID: 16392766 [Abstract] [Full Text] [Related]
15. Effects of valsartan with or without benazepril on blood pressure, angiotensin II, and endoxin in patients with essential hypertension. Ke YS, Tao YY, Yang H, Yu GH. Acta Pharmacol Sin; 2003 Apr 14; 24(4):337-41. PubMed ID: 12676074 [Abstract] [Full Text] [Related]
17. Long-term anti-hypertensive therapy with benidipine improves arterial stiffness over blood pressure lowering. Kita T, Suzuki Y, Eto T, Kitamura K. Hypertens Res; 2005 Dec 14; 28(12):959-64. PubMed ID: 16671334 [Abstract] [Full Text] [Related]
18. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP. Pu Q, Brassard P, Javeshghani DM, Iglarz M, Webb RL, Amiri F, Schiffrin EL. J Hypertens; 2008 Feb 14; 26(2):322-33. PubMed ID: 18192847 [Abstract] [Full Text] [Related]